Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of antiangiogenic therapies

Article

Abstract: Purpose: Despite the wide use of antiangiogenic drugs in the clinical setting, predictive biomarkers

Palabras claves:

Autores:

Albarran M.I., Alvarez R., Banos N., Blanco-Aparicio C., Camacho-Artacho M., Cubillo A., De Martino A., Domínguez O., Durán Y., Garralda E., Hidalgo M., Lietha D., Martínez-Torrecuadrada J.L., Mitsi M., Monsech J., Otero A., Perea S., Pons T., Sanchez-Perez T., Sarno F., Toledo R.A., Vega E., Victoria Maritza Cevallos Bonilla

Fuentes:

scopus